Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

September 20, 2019

Clinical Articles

Chronic myeloid leukemia is a rare type of cancer, and tyrosine kinase inhibitors have become the standard guideline-recommended treatment for patients with BCR-ABL1–positive or Ph-positive CML.